Sagimet Biosciences, Inc. (SGMT)
Sagimet Biosciences Market Cap : 162.91M for Feb. 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 10.55B |
| ACADIA Pharmaceuticals, Inc. | 3.727B |
| Agenus, Inc. | 105.53M |
| Alnylam Pharmaceuticals, Inc. | 41.70B |
| Savara, Inc. | 1.139B |
Market Cap Related Metrics
| PEG Ratio | -0.074 |
| Price to Book Value | 1.366 |
| Price | 5.06 |
| Earnings Yield | -35.34% |
| PEGY Ratio | -0.074 |